Medscape June 2, 2024
Two common cost-containment strategies — high-deductible health plans and stringent prior authorization requirements — can significantly hinder the survival and well-being of patients with cancer, according to two studies presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
In the first study, Justin Barnes, MD, with Washington University in St. Louis, and colleagues used data from the National Health Interview Survey (2011-2018) to analyze the impact of high-deductible health plans — which often result in higher out-of-pocket expenses for patients before insurance coverage kicks in — on overall and cancer-specific survival.
High-deductible health plans were defined as a yearly deductible of $1200 to $1350 or more for an individual, and $2400 to $2700 for a family....
Today's Sponsors
Today's Sponsor